Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
出版年份 2017 全文链接
标题
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-08-23
DOI
10.3389/fphar.2017.00556
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease
- (2018) Alessandro Cannavo et al. CELLULAR SIGNALLING
- Selective coupling of the S1P 3 receptor subtype to S1P-mediated RhoA activation and cardioprotection
- (2017) Bryan S. Yung et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- S1P receptor 1-Mediated Anti–Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2
- (2017) Alice Marino et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- β 1 -Blockade Prevents Post-Ischemic Myocardial Decompensation Via β 3 AR-Dependent Protective Sphingosine-1 Phosphate Signaling
- (2017) Alessandro Cannavo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
- (2017) Mario Ruiz et al. Lipids in Health and Disease
- Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
- (2017) Sinead O'Sullivan et al. NEUROPHARMACOLOGY
- Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination
- (2017) Wen-Na Shi et al. Oncotarget
- Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk
- (2016) Kunio Sugahara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sphingosine-1-phosphate reduces ischaemia–reperfusion injury by phosphorylating the gap junction protein Connexin43
- (2016) Sandrine Morel et al. CARDIOVASCULAR RESEARCH
- Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/ReperfusionCLINICAL PERSPECTIVE
- (2016) Carlos G. Santos-Gallego et al. CIRCULATION
- Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development
- (2016) Hilary Clay et al. DEVELOPMENTAL BIOLOGY
- Targeting Β-3 Adrenergic Receptors In The Heart-Selective Agonism And Β-Blockade
- (2016) Alessandro Cannavo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
- (2016) Susan Pyne et al. PROGRESS IN LIPID RESEARCH
- Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice
- (2016) Vanessa H. Brait et al. STROKE
- Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases
- (2016) Alessandro Cannavo et al. Nature Communications
- Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+Sensitivity and Na+/H+Exchange and Mediates Protection by Ischemic Preconditioning
- (2016) Petra Keul et al. Journal of the American Heart Association
- Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans
- (2016) Irina Soltau et al. PLoS One
- Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury
- (2015) Matthew L. Stone et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury
- (2015) D Goltz et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Sphingosine-1-Phosphate Receptor Subtype 2 Signaling in Endothelial Senescence-Associated Functional Impairments and Inflammation
- (2015) Jiawei Zhao et al. Current Atherosclerosis Reports
- Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
- (2015) Jason Newton et al. EXPERIMENTAL CELL RESEARCH
- Fingolimod effects on left ventricular function in multiple sclerosis
- (2015) Vittorio Racca et al. Multiple Sclerosis Journal
- Fingolimod effects on left ventricular function in multiple sclerosis
- (2015) Vittorio Racca et al. Multiple Sclerosis Journal
- FTY720 attenuates hypoxia–reoxygenation-induced apoptosis in cardiomyocytes
- (2014) Min Wang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Adipocyte Lipolysis-stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity
- (2014) Wenliang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection
- (2014) Xia Zhao et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- β-adrenergic receptor responsiveness in aging heart and clinical implications
- (2014) Nicola Ferrara et al. Frontiers in Physiology
- Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation
- (2013) Alessandro Cannavo et al. APOPTOSIS
- AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose
- (2013) Kaipeng Huang et al. CELLULAR SIGNALLING
- β 1 -Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure
- (2013) Alessandro Cannavo et al. CIRCULATION
- Review: Novel insights into the regulation of vascular tone by sphingosine 1-phosphate
- (2013) D. Kerage et al. PLACENTA
- Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction
- (2013) Małgorzata Knapp et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- PLC , PKD1, and SSH1L Transduce RhoA Signaling to Protect Mitochondria from Oxidative Stress in the Heart
- (2013) S. Y. Xiang et al. Science Signaling
- Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
- (2013) Emmanuel E. Egom et al. Frontiers in Physiology
- Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
- (2013) Alessandro Cannavo et al. Frontiers in Physiology
- Sphingosine kinase and sphingosine 1-phosphate in the heart: A decade of progress
- (2012) Joel S. Karliner BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
- (2012) P Gergely et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis
- (2012) Jerry E. Chipuk et al. CELL
- Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier
- (2012) Brent A. Wilkerson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fingolimod for Multiple Sclerosis
- (2012) Daniel Pelletier et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat
- (2012) Ryan M. Fryer et al. PLoS One
- S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart
- (2011) Padmavathi Bandhuvula et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection
- (2011) Ludovic Gomez et al. BASIC RESEARCH IN CARDIOLOGY
- Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system
- (2011) Mirjam Schuchardt et al. BRITISH JOURNAL OF PHARMACOLOGY
- The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner
- (2011) Ashok Kumar et al. CELLULAR SIGNALLING
- AKT signalling in the failing heart
- (2011) Antoine H. Chaanine et al. EUROPEAN JOURNAL OF HEART FAILURE
- A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression
- (2011) Shuo Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
- (2011) Kelley M Argraves et al. Lipids in Health and Disease
- Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats
- (2011) Hongwei Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation
- (2011) T. Hla et al. NEUROLOGY
- A Sphingosine Kinase Form 2 Knockout Sensitizes Mouse Myocardium to Ischemia/Reoxygenation Injury and Diminishes Responsiveness to Ischemic Preconditioning
- (2011) Donald A. Vessey et al. Oxidative Medicine and Cellular Longevity
- Sphingosine-1-phosphate signaling and its role in disease
- (2011) Michael Maceyka et al. TRENDS IN CELL BIOLOGY
- S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate
- (2010) William S. Szczepaniak et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
- (2010) Katherine J. E. Sattler et al. BASIC RESEARCH IN CARDIOLOGY
- FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
- (2010) Francesca Tonelli et al. CELLULAR SIGNALLING
- Fingolimod for the treatment of relapsing multiple sclerosis
- (2010) Douglas R Jeffery et al. Expert Review of Neurotherapeutics
- Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration
- (2010) Graham M. Strub et al. FASEB JOURNAL
- Sphingosine Protects Aging Hearts from Ischemia/Reperfusion Injury: Superiority to Sphingosine 1-Phosphate and Ischemic Pre- and Post-Conditioning
- (2010) Donald A. Vessey et al. Oxidative Medicine and Cellular Longevity
- Regulation of sphingosine kinase and sphingolipid signaling
- (2010) Stuart M. Pitson TRENDS IN BIOCHEMICAL SCIENCES
- Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor- -stimulated collagen production by cardiac fibroblasts
- (2009) N. Gellings Lowe et al. CARDIOVASCULAR RESEARCH
- Sphingosine-1-phosphate receptor signalling in the heart
- (2009) C. K. Means et al. CARDIOVASCULAR RESEARCH
- Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia–reperfusion
- (2009) Ulrich Hofmann et al. CARDIOVASCULAR RESEARCH
- Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype
- (2009) Andreas Weigert et al. INTERNATIONAL JOURNAL OF CANCER
- Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection
- (2009) Joel S Karliner JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling
- (2009) E. Eroume A Egom et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
- (2009) J. Guillermet-Guibert et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
- (2009) N. C. Hait et al. SCIENCE
- Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner
- (2008) Lotte P. Hofmann et al. BIOLOGICAL CHEMISTRY
- Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
- (2008) Krishnan Venkataraman et al. CIRCULATION RESEARCH
- Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival
- (2008) J. Li et al. CLINICAL CANCER RESEARCH
- Targeting SphK1 as a New Strategy against Cancer
- (2008) Dai Shida et al. CURRENT DRUG TARGETS
- S1P1Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile Responses
- (2008) Christopher Kable Means et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysophospholipid receptors in vertebrate development, physiology, and pathology
- (2008) Athanasia Skoura et al. JOURNAL OF LIPID RESEARCH
- Thematic Review Series: Sphingolipids.Biodiversity of sphingoid bases (“sphingosines”) and related amino alcohols
- (2008) Sarah T. Pruett et al. JOURNAL OF LIPID RESEARCH
- Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes
- (2007) Lee K. Landeen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools
- (2007) S Salomone et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now